BXP
55
-4
VTR
50
-5
MRK
35
-5
FCX
59
2
WYNN
42
4
DGX
44
-3
PX
76
-2
CMCSA
50
2
KMI
67
4
STZ
58
5
AMGN
33
2
PLD
56
-2
CHRW
42
-12
PRGO
40
-3
PEP
53
3
FSLR
50
4
VRSN
59
-4
PSA
61
-2
DRI
60
2
PNC
65
-2
BXP
55
-4
VTR
50
-5
MRK
35
-5
FCX
59
2
WYNN
42
4
DGX
44
-3
PX
76
-2
CMCSA
50
2
KMI
67
4
STZ
58
5
AMGN
33
2
PLD
56
-2
CHRW
42
-12
PRGO
40
-3
PEP
53
3
FSLR
50
4
VRSN
59
-4
PSA
61
-2
DRI
60
2
PNC
65
-2
Financhill
Back

American Financial Group Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
55

AFG
American Financial Group

Last Price:
147.07
Seasonality Move:
4.27%
Buy
58

SRPT
Sarepta Therapeutics

Last Price:
133.49
Seasonality Move:
14.88%
Buy
55
American Financial Group (AFG) is a Buy

Is American Financial Group a Buy, Sell or Hold?

  • The current American Financial Group [AFG] share price is $146.86. The Score for AFG is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • AFG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $133.34. The Score for SRPT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

AFG Stock Price Chart

What is American Financial Group's stock price today?

  • The American Financial Group share price today is $146.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AFG is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $133.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

AFG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.64 Buy
Relative Strength Index (14 RSI): 64.2 Buy
Chaikin Money Flow: -147357 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (130.5 - 145.22) Buy
Bollinger Bands (100): (127.19 - 138.97) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.78 Buy
Relative Strength Index (14 RSI): 63.54 Buy
Chaikin Money Flow: -725343 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (110.85 - 129.81) Buy
Bollinger Bands (100): (119.21 - 141.67) Buy

AFG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 145.17 Buy
20-day SMA: 139.96 Buy
50-day SMA: 136.6 Buy
200-day SMA: 130.72 Buy
8-day EMA: 145.54 Buy
20-day EMA: 141.58 Buy
50-day EMA: 137.44 Buy
200-day EMA: 130.65 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 119.83 Buy
20-day SMA: 118.14 Buy
50-day SMA: 122.33 Buy
200-day SMA: 130.09 Buy
8-day EMA: 123.82 Buy
20-day EMA: 120.48 Buy
50-day EMA: 122.96 Buy
200-day EMA: 126.17 Buy

American Financial Group Earnings Growth & AFG Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $1.18 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $7.74 per share.

American Financial Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):